Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Training Primary Care Physicians to Perform Melanoma Opportunistic Surveillance

NCT02385253

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations: Northwestern Medicine: Division of General Internal Medicine and Geriatrics Chicago, Illinois, United States

Northwestern University Feinberg School of Medicine Department of Dermatology Chicago, Illinois, United States

View Trial Details

Completed

A Study of Tasisulam in Treating Participants With Malignant Melanoma

NCT00383292

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lakeland, Florida, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States

View all 13 locations

View Trial Details

Completed

A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma

NCT00804908

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +11 more
Locations: Not specified

View Trial Details

Completed

A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity of Trametinib in Combination With Palbociclib in Subjects With Solid Tumors

NCT02065063

Conditions: Cancer, Melanoma, Neoplasms, +10 more
Locations: GSK Investigational Site Boston, Massachusetts, United States

GSK Investigational Site Nashville, Tennessee, United States

GSK Investigational Site Houston, Texas, United States

View Trial Details

Completed

Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream

NCT02685592

Conditions: Hutchinson's Melanotic Freckle, Lentigo Maligna, Melanoma, +7 more
Locations: Päijät-Häme Central Hospital Lahti, Finland

View Trial Details

Completed

Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma

NCT03541148

Conditions: Cutaneous Melanoma, Stage II, Cutaneous Melanoma, Stage III, Malignant Cutaneous Melanoma, +13 more
Locations: Manuel Fajardo Clinical Surgical University Hospital La Habana, Cuba

View Trial Details

Completed

VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

NCT00450255

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma, Eye Diseases, +22 more
Locations: City of Hope Duarte, California, United States

View Trial Details

Completed

The Jules Bordet Institute Molecular Profiling Program Feasibility Trial

NCT01932489

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +20 more
Locations: Jules Bordet Institute Brussels, Belgium

View Trial Details

Completed

Assessing Quality of Life Tools in Medullary Thyroid Cancer Patients

NCT02465424

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
Locations: Velindre Hospital Cardiff, United Kingdom

University Hospitals of Coventry and Warwickshire Coventry, United Kingdom

Western general Hospital Edinburgh, United Kingdom

Imperial Hospital London, United Kingdom

View Trial Details

Completed

Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity

NCT01323517

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions